Keyphrases
Interleukin-1β
100%
Interleukin-6
100%
Methotrexate
100%
Monocytic Cells
100%
U937
100%
C-Jun N-terminal Kinase
27%
U937 Cells
27%
Rheumatoid Arthritis
18%
Observed Effects
18%
Gene Expression
9%
Tumor Necrosis Factor-α
9%
Secreted Proteins
9%
Dose Effect
9%
Mechanism of Action
9%
JNK2
9%
Nuclear factor-κB
9%
Inflammatory Cytokines
9%
Pharmacologic
9%
Malignancy
9%
Kinase Cascade
9%
Pneumonitis
9%
Immune Function
9%
Folate
9%
Theophylline
9%
Adenosine
9%
Human Monocytic Cell Line
9%
Cytokine Expression
9%
Caffeine
9%
Changes in Gene Expression
9%
Decreased Bone Density
9%
Anti-inflammatory Effect
9%
Mucositis
9%
Immunology and Microbiology
Cell Line
100%
Interleukin 1
100%
Interleukin 6
100%
Methotrexate
100%
Amino Terminal Sequence
27%
Inflammatory Arthritis
18%
Gene Expression
18%
Cytokine
18%
Signal Transduction
9%
Proinflammatory Cytokine
9%
Pneumonitis
9%
Theophylline
9%
Bone Density
9%
Tumor Necrosis Factor Alpha
9%
Antiinflammatory Activity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 1
100%
Interleukin 6
100%
Methotrexate
100%
Phosphotransferase
27%
Cytokine
27%
Adenosine
18%
Rheumatoid Arthritis
18%
Folic Acid
18%
Disease
9%
Tumor Necrosis Factor
9%
Pneumonia
9%
Theophylline
9%
Antiinflammatory Activity
9%
Mucosa Inflammation
9%